Navigation Links
CorVel Announces Revenues and Earnings
Date:6/4/2009

IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL) reported earnings per share of $0.33 for the quarter ended March 31, 2009, compared to $0.44 in the same quarter of the prior year. For the fiscal year ended March 31, 2009 earnings were $1.42 per share compared to the prior fiscal year of $1.67 per share.

The Company reported quarterly revenues of $77 million, comparable to the prior year's March quarterly revenue of $77 million. For the fiscal year ended March 31, 2009, revenues were $310 million, representing a 2.7% increase from the $302 million in revenues achieved in the prior fiscal year.

During the March quarter and throughout fiscal 2009, the Company has continued to expand its workers' compensation claims management solutions. During the March quarter, CorVel completed the acquisition of a third party administrator (TPA) in New York, the Company's third acquisition in its TPA expansion effort. Software development efforts have been focused on the incorporation of artificial intelligence capabilities and workflow management tools in to the claims management systems in order to enable CorVel's unique process.

Also in the March quarter, the company continued its Medicare Agent Services initiative. Recent legislation has expanded the definition of the administrative requirements designed to protect the Medicare system from medical expenses considered the primary obligation of private sector plans, including insured and self-insured workers' compensation, liability and no fault plans. These new regulations include a provision that requires claims with the potential to be covered under the Centers for Medicare/Medicaid Services (CMS) regulations to be communicated to the Coordination of Benefits Contractor either directly by parties at risk or by their "Agent". The Act emp
'/>"/>

SOURCE CorVel Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. CorVel Announces Fiscal Year Earnings Release Webcast
2. CorVel Corporation Announces Earnings Release Webcast
3. CorVel Announces Second Quarter Revenues and Earnings
4. CorVel Announces Expanded Share Buyback
5. CorVel Announces Record Earnings
6. CorVel Announces Appearance at Bank of America Health Care Conference
7. CorVel to Present at UBS Global Healthcare Services Conference
8. CorVel Announces Record Earnings Per Share
9. CorVel Corporation Announces Resumption of Stock Repurchases
10. Conceptual Options, a Center for Surrogacy & Egg Donation, Announces Third Party Assurance Program
11. Orlando Dermatology Aesthetic & Clinical (ODAC) Conference Announces Its 2010 Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Now that Thanksgiving is finally here ... Emassagechair.com has announced its eagerly awaited, once ... , Negotiating on behalf of their customers, and drawing ... Emassagechair.com has generated significant buzz in the industry with ... yet. , Shoppers are excited for significant savings available ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part of its ... products available to consumers. Mallory Sofastaii, a technology expert and ... shared with viewers the company offers a cable case, iBed, ... love portability and functionality. A unique mobile company at ... and 5S has a portable USB charger built in. The ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
(Date:11/27/2014)... In addition to a new dessert recipe or family ... season and become educated about the warning signs of ... holidays may raise questions about the physical and cognitive ... ability can occur with age, serious memory problems are ... between normal aging and more serious problems can help ...
Breaking Medicine News(10 mins):Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... Nurse Practitioner and herbalist announces her first product, Omyst™, a healing ... successfully tested on over 2,000 patients and has been clinically proven ... insect bites, stings and sutures. , ... New York, ...
... is committed to bringing new acai health product reviews to the masses ... available on the market today. , ... Green Bay, WI (PRWEB) November ... new acai health product reviews to the masses by providing accurate descriptions ...
... WARSAW, Ind., Nov. 6 Zimmer Holdings, Inc.,(NYSE: ... it has become the founding,supporter of a new ... provide funding for post-graduate orthopaedic fellowships and,residency programs, ... entity, called OMeGA Medical Grants Association LLC (OMeGA),will ...
... 6 Lumenis(R) Ltd. a global,developer, manufacturer and ... surgical and aesthetic applications,announced today that it will ... November 8th at the American Academy of Ophthalmology,(AAO) ... Lumenis, President and Chief Executive Officer stated:,"Lumenis is ...
... 6 The following was released today,by Dr. ... report from the U.S. Department of Veterans Affairs ... waste,mismanagement and inaction to disclosures of fraud, waste, ... Veterans Health,Care System (CTVHCS)., Inaction to these ...
... (Nasdaq: MBRK ), a pharmaceutical company focused ... three patents protecting Moxatag (amoxicillin,extended-release) Tablets, 775mg, were ... 2008, pursuant to Section 4 of Public Law ... MiddleBrook President & CEO John Thievon said, ...
Cached Medicine News:Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 2Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 3Health News:Acai Berry Health Foods Heightens Consumer Awareness of the Purple Miracle Berry 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 2Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 4Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4
(Date:11/26/2014)... LOVELAND, Colo. , Nov. 25, 2014   Heska ... ; "Heska" or the "Company"), a provider of advanced ... Dr. Robert Grieve , Executive Chair, will attend The ... 11, 2014. The one-on-one conference will be held at The ... IL from 8 a.m. to 2:30 p.m. Please ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen (NASDAQ: ... ) today announced that AMAGINE-2 TM , a pivotal, multi-arm ... than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary ... placebo at week 12. Brodalumab 210 mg given every two ... to be superior to Stelara on the primary endpoint of ...
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3
... of treating upper extremity fractures with ... many studies. , ,Intramedullary nailing using ... offers the benefits of anatomic alignment, ... dissection and early rehabilitation of the ...
... An innovative new system to help you ... The system's one-piece design creates a ... enhances postoperative radiographic assessment. The slotted superior ... the central column and are flared outward ...
... The QuickSite model 1056K LV lead ... and to promote shorter procedure times, ... performance, and reliability., ,The QuickSite LV ... advanced left ventricular lead, including such ...
... The AIM Titanium Tibial Nail ... the mechanical failures of existing ... for tibial interlocking nails. It ... range of diameters and lengths ...
Medicine Products: